Quince Therapeutics Dividend
Dividend criteria checks 0/6
Quince Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$0.73 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Here's Why We're Watching Quince Therapeutics' (NASDAQ:QNCX) Cash Burn Situation
Nov 21Cortexyme to change name and ticker symbol next month
Jul 27Cortexyme: A Biotech Worth A Look Based On Potential Alzheimer's Treatment
Mar 01Cortexyme: Drug Candidate COR588 May Offer Some Hope To Investors
Dec 15We're Keeping An Eye On Cortexyme's (NASDAQ:CRTX) Cash Burn Rate
Dec 15Cortexyme: A Challenging Path Forward
Nov 17Cortexyme: Positive Lessons To Be Learned From Disappointing Results
Nov 01Cortexyme And The Gingipain Hypothesis Of Alzheimer's Disease
Oct 11Cortexyme: Alzheimer's Readout In November A Binary Event
Sep 12We Think Cortexyme (NASDAQ:CRTX) Can Afford To Drive Business Growth
Aug 23Cortexyme EPS beats by $0.02
May 10We're Not Very Worried About Cortexyme's (NASDAQ:CRTX) Cash Burn Rate
May 10Insider Buying: The Cortexyme, Inc. (NASDAQ:CRTX) Independent Director Just Bought 2.4% More Shares
Mar 10Companies Like Cortexyme (NASDAQ:CRTX) Are In A Position To Invest In Growth
Feb 09Cortexyme: A Fresh Perspective In Alzheimer's
Jan 12Have Insiders Been Buying Cortexyme, Inc. (NASDAQ:CRTX) Shares This Year?
Dec 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if QNCX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if QNCX's dividend payments have been increasing.
Dividend Yield vs Market
Quince Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (QNCX) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (QNCX) | 0% |
Notable Dividend: Unable to evaluate QNCX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate QNCX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate QNCX's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as QNCX has not reported any payouts.